• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.95% Nasdaq Down2.40%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    13.80 Down 0.28(1.99%) Jun 29, 4:00PM EDT
    |After Hours : 13.80 0.00 (0.00%) Jun 29, 6:46PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 11,427   48,300   13,203   5,743  
    Cost of Revenue -   -   -   -  
    Gross Profit 11,427   48,300   13,203   5,743  
    Operating Expenses
    Research Development25,666  27,647  28,018  25,787  
    Selling General and Administrative7,000  6,872  7,095  6,456  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (21,239) 13,781   (21,910) (26,500)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  1  
    Earnings Before Interest And Taxes(21,618)13,635  (22,282)(26,499)
    Interest Expense -   -   -   -  
    Income Before Tax(21,618)13,635  (22,282)(26,499)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(21,618)13,635  (22,282)(26,499)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (21,618) 13,635   (22,282) (26,499)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (21,618) 13,635   (22,282) (26,499)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.